167 related articles for article (PubMed ID: 6165072)
41. Evaluation of six tests for circulating IgG complexes with special reference to IgM rheumatoid factors: analysis of systemic lupus erythematosus and rheumatoid arthritis series.
Wager O; Lindström P; Räsänen JA; Kekomäki R; Ziola B; Salmi A; Isomäki H; Skrifvars B; Penttinen K
Clin Exp Immunol; 1981 Oct; 46(1):149-60. PubMed ID: 7337967
[TBL] [Abstract][Full Text] [Related]
42. Epitope sites on human beta 2-microglobulin identified by xenogeneic polyclonal and monoclonal antisera.
Sanderson AR; Ward PJ
Immunology; 1981 Sep; 44(1):169-75. PubMed ID: 6168569
[TBL] [Abstract][Full Text] [Related]
43. Antibodies to and elevations of beta 2 microglobulin in the serum of ankylosing spondylitis patients.
Curry R; Thoen J; Shelborne C; Gaudernack G; Messner R
Arthritis Rheum; 1982 Apr; 25(4):375-80. PubMed ID: 6176246
[TBL] [Abstract][Full Text] [Related]
44. Precipitation of 19S IgM rheumatoid factor-IgG circulating immune complexes in patients with juvenile arthritis by polyethylene glycol and separation by immobilized protein A.
Moore TL; Dorner RW; Sheridan PW; Zuckner J
Clin Exp Immunol; 1984 May; 56(2):247-52. PubMed ID: 6733970
[TBL] [Abstract][Full Text] [Related]
45. Serum and synovial fluid inhibitors of antibody-mediated lymphocytotoxicity in rheumatoid arthritis and systemic lupus erythematosus.
Arthritis Rheum; 1976; 19(2):142-9. PubMed ID: 56939
[TBL] [Abstract][Full Text] [Related]
46. IgA containing immune complexes in rheumatoid vasculitis and in active rheumatoid disease.
Westedt ML; Daha MR; de Vries E; Valentijn RM; Cats A
J Rheumatol; 1985 Jun; 12(3):449-55. PubMed ID: 4045842
[TBL] [Abstract][Full Text] [Related]
47. Rheumatoid arthritis: an immune complex disease? A review of the reaction of antigen with antibody to form immune complexes and the mechanisms by which they mediate tissue injury.
Hester RB; Bennett JC
Geriatrics; 1973 Jun; 28(6):84-91. PubMed ID: 4126064
[No Abstract] [Full Text] [Related]
48. Nature of double-stranded DNA binding activity in seropositive rheumatoid arthritis: formation of low avidity DNA/rheumatoid factor/IgG/low density lipoprotein complexes.
Winfield JB; Shaw M; Taylor RP; Eisenberg RA
J Immunol; 1981 Apr; 126(4):1596-602. PubMed ID: 6162894
[TBL] [Abstract][Full Text] [Related]
49. Circulating immune complexes and complement in rheumatoid arthritis.
Duquesnoy B
Ann Biol Clin (Paris); 1984; 42(1):71-5. PubMed ID: 6375473
[TBL] [Abstract][Full Text] [Related]
50. Isolation and analysis of complement activating aggregates from synovial fluid of patients with rheumatoid arthritis using monoclonal anti-C3d antibodies.
Bedwell AE; Elson CJ; Carter SD; Dieppe PA; Hutton CW; Czudek R
Ann Rheum Dis; 1987 Jan; 46(1):55-64. PubMed ID: 3492971
[TBL] [Abstract][Full Text] [Related]
51. Complexed rheumatoid factor measurements in sera, synovial fluids and in immune complex fractions.
Falus A; Merétey K; Böhm U; Bozsóky S
Experientia; 1979 Mar; 35(3):413-4. PubMed ID: 36289
[TBL] [Abstract][Full Text] [Related]
52. Characterization of IgG complexes in patients with rheumatoid arthritis.
Winchester RJ
Ann N Y Acad Sci; 1975 Jun; 256():73-81. PubMed ID: 808994
[TBL] [Abstract][Full Text] [Related]
53. Distinct oligosaccharide content of rheumatoid arthritis-derived immune complexes.
Bond A; Kerr MA; Hay FC
Arthritis Rheum; 1995 Jun; 38(6):744-9. PubMed ID: 7779116
[TBL] [Abstract][Full Text] [Related]
54. [Study of the mechanism of the fall in complement levels in the synovial fluid in rheumatoid arthritis. II. Demonstration of an abnormal anti-complement property in rheumatoid synovial fluids].
Peltier AP; Vial MC; Leroy C; de Sèze S
Pathol Biol (Paris); 1970 Nov; 18(21):969-74. PubMed ID: 4099022
[No Abstract] [Full Text] [Related]
55. Circulating immune complexes in the serum in systemic lupus erythematosus and in carriers of hepatitis B antigen. Quantitation by binding to radiolabeled C1q.
Nydegger UE; Lambert PH; Gerber H; Miescher PA
J Clin Invest; 1974 Aug; 54(2):297-309. PubMed ID: 4847246
[TBL] [Abstract][Full Text] [Related]
56. The detection of immune complexes of different immunoglobulin class.
Quin JW; Charlesworth JA; Macdonald GJ
Aust N Z J Med; 1979 Dec; 9(6):644-9. PubMed ID: 294921
[TBL] [Abstract][Full Text] [Related]
57. Platelets as target cells in rheumatoid arthritis and systemic lupus erythematosus: a platelet specific immunoglobulin inducing the release reaction.
Weissbarth E; Baruth B; Mielke H; Liman W; Deicher H
Rheumatol Int; 1982; 2(2):67-73. PubMed ID: 6217534
[TBL] [Abstract][Full Text] [Related]
58. Quantitation and characterization of soluble immune complexes precipitated from sera by polyethylene glycol (PEG).
Chia D; Barnett EV; Yamagata J; Knutson D; Restivo C; Furst D
Clin Exp Immunol; 1979 Sep; 37(3):399-407. PubMed ID: 315842
[TBL] [Abstract][Full Text] [Related]
59. [Clinical application of Fc-rosette. III. Reduction of Fc receptor bearing cells in the peripheral blood of SLE and rheumatoid synovial fluids (author's transl)].
Nakai H; Morito T; Tanimoto K; Horiuchi Y
Ryumachi; 1977 Jul; 17(4):373-80. PubMed ID: 905902
[No Abstract] [Full Text] [Related]
60. Studies with human leukocyte lysosomes. Evidence for antilysosome antibodies in lupus erythematosus and for the presence of lysosomal antigen in inflammatory diseases.
Bell DA; Thiem PA; Vaughan JH; Leddy JP
J Clin Invest; 1975 Feb; 55(2):256-68. PubMed ID: 1092714
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
